Viewing Study NCT04435366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-25 @ 1:11 AM
Study NCT ID: NCT04435366
Status: COMPLETED
Last Update Posted: 2025-10-21
First Post: 2020-05-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
Sponsor: IVERIC bio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Geographic Atrophy View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Geographic Atrophy (GA) View
None Age-related Macular Degeneration View
None AMD View
None Complement C5 inhibitor View
None avacincaptad pegol View
None IZERVAY View